Technology

Serverless, HIPAA-compliant infrastructure purpose-built for medical imaging AI.

Prostate MRI AI

End-to-end automated biparametric MRI analysis. From study upload to structured report, every step of the prostate MRI workflow is streamlined.

Automated Series Selection

Configure your institution's series naming conventions once, and the platform remembers. T2-weighted, ADC, and high b-value DWI series are automatically identified and populated from any scanner vendor — eliminating manual series selection on every case.

Drag-and-drop series selection interface for T2, ADC, and High B Value series
Aligned MRI viewer showing T2, ADC, and High B Value in same voxel space

Automated Image Alignment

All biparametric series (T2, ADC, high b-value) are automatically registered into the same voxel space using affine alignment. Scroll through any slice and all three sequences stay perfectly synchronized — enabling direct visual comparison of signal characteristics across modalities.

AI Segmentation & Lesion Detection

State-of-the-art deep learning models automatically segment the whole prostate boundary and transition zone, then identify candidate lesions. Contours are delivered as standard DICOM RTSTRUCT objects that can be edited directly in the viewer or exported to external systems.

AI-generated prostate boundary and lesion segmentation contours
Auto-windowed biparametric MRI display with optimized window/level settings

Automated Windowing

Window and level settings are automatically optimized based on published guidelines for biparametric prostate MRI. Each sequence type receives appropriate windowing for lesion visualization without manual adjustment.

PSA Density Risk Assessment

Prostate volume derived from AI segmentation is combined with the patient's PSA value to calculate PSA density. A CHAID decision tree model — validated on 992 patients — estimates the probability of clinically significant cancer (Gleason 7+), with risk category and evidence-based interpretation.

PSA density risk assessment panel showing probability of clinically significant cancer
Automated biparametric prostate MRI report with findings and risk assessment

Automated Report Generation

A structured radiology report is generated automatically, including patient demographics, technique description extracted from DICOM headers, findings with lesion characterization, PSA density risk assessment, and overall impression. Reports follow standard biparametric MRI reporting templates.

Navigo Fusion Biopsy Integration

AI segmentation contours and lesion targets can be exported directly to the Philips Navigo MRI/ultrasound fusion biopsy platform. One-click export from the viewer generates compatible output files, eliminating the manual re-contouring step that typically precedes targeted biopsy.

Philips Navigo MRI/ultrasound fusion biopsy workstation

Upcoming

New AI capabilities currently in development on the Acurix platform.

PET/CT Viewer

Native PET/CT viewing with true fusion display, SUV measurement, and Maximum Intensity Projection (MIP). Standard PACS systems often struggle to display PET scans natively — rendering them as static screenshots rather than interactive volumes, with no ability to measure SUV uptake, adjust colormap thresholds, or scroll through fused PET/CT slices.

Acurix renders PET and CT volumes as fully interactive overlays with adjustable fusion opacity, multiple PET colormaps, and real-time SUV quantification at any point in the volume. MIP projections provide a whole-body overview for rapid lesion localization — all from a standard web browser with no specialized workstation required.

PET/CT fusion viewer with SUV measurement, colormap overlay, and MIP projection

Focal Therapy Planning

NanoKnife IRE focal therapy treatment planning with probe placement and treatment zones

NanoKnife IRE (irreversible electroporation) treatment planning directly within the imaging viewer. Using the AI-generated prostate boundary and lesion segmentation as inputs, the system computes optimal probe placement to maximize lesion coverage with a safety margin.

Five probes are placed across four treatment phases, generating 10 treatment zones. Coverage fraction is computed in real time. Probes can be manually adjusted with zones recomputing automatically. The final plan is saved as a multi-slice DICOM RTSTRUCT for integration with treatment delivery systems.

Platform Capabilities

Cloud PACS

Integrated DCM4CHEE PACS with OHIF web viewer. Studies accessible from any browser without local DICOM software.

Multi-Site Ingestion

Connect existing PACS via DIMSE, SFTP, HTTP push, or C-MOVE pull. No changes to existing infrastructure required.

GPU Processing

AWS Batch with on-demand GPU instances. Models run on the latest NVIDIA hardware without any capital expenditure.

Multi-Tenant Isolation

Each organization gets cryptographically isolated data. Patient IDs are prefixed, S3 paths are segmented, and queries are filtered per tenant.

DICOM Standards

All results delivered as standard DICOM objects: RTSTRUCT for segmentations, DICOM SR for structured reports, standard series for aligned images.

Rapid Model Onboarding

Any containerized AI model can be deployed on the platform. Shared infrastructure for storage, compute, viewer integration, and HIPAA compliance.

HIPAA Compliance

Security and compliance are built into every layer, not bolted on afterward.

Encryption at Rest

AES-256 encryption for all stored data: S3, RDS, EFS. AWS KMS managed keys.

Encryption in Transit

TLS 1.2+ enforced across all connections. HSTS headers on all endpoints.

Audit Logging

Every PHI access event is logged to CloudWatch with 7-year retention. Full request tracing via AWS X-Ray.

See the platform in action

See how Acurix AI can transform your imaging workflow.

Schedule a Demo